Haemostatic problems in acute leukaemia.

[1]  D. Feinstein.  Treatment of Disseminated Intravascular Coagulation , 1988, Seminars in thrombosis and hemostasis.

[2]  D. Swirsky,et al.  Beneficial effect of heparin in the management of patients with APL , 1988, British journal of haematology.

[3]  D. Mosher,et al.  Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency. , 1986, Annals of internal medicine.

[4]  E. Estey,et al.  Acute promyelocytic leukemia. M.D. Anderson Hospital experience. , 1986, The American journal of medicine.

[5]  V. Napoli,et al.  Fluorometric assay of antithrombin III. Diagnostic value in 112 patients with abnormal hemostasis. , 1985, American journal of clinical pathology.

[6]  B. Lämmle,et al.  Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). , 1984, American journal of clinical pathology.

[7]  K. Bauer,et al.  Thrombin generation in acute promyelocytic leukemia. , 1984, Blood.

[8]  B. Bennett,et al.  Plasmin‐a2‐antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis , 1984, British journal of haematology.

[9]  T. Barbui,et al.  Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia , 1984 .

[10]  R. Canfield,et al.  FIBRINOPEPTIDE RELEASE FROM FIBRINOGEN * , 1983, Annals of the New York Academy of Sciences.

[11]  E. Wilson,et al.  The secretion of plasminogen activators by human myeloid leukemic cells in vitro. , 1983, Blood.

[12]  A. Levine,et al.  Antithrombin III and anti‐activated factor × activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin , 1982, Cancer.

[13]  Harpel,et al.  Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. , 1982, The Journal of biological chemistry.

[14]  E. Plow.  Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. , 1982, The Journal of clinical investigation.

[15]  F. Rickles,et al.  Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity. , 1981, Blood.

[16]  C. Schiffer,et al.  Acute promyelocytic leukemia—clinical management of 15 patients , 1980, American journal of hematology.

[17]  R. Bick,et al.  Antithrombin III patterns in disseminated intravascular coagulation. , 1980, American journal of clinical pathology.

[18]  C. Bloomfield,et al.  Acute Promyelocytic Leukemia: Management of the Coagulopathy During Daunorubicin-Prednisone Remission Induction , 1978 .

[19]  P. Ganguly,et al.  Defective Binding of Thrombin to Platelets in Myeloid Leukaemia , 1978, British journal of haematology.

[20]  A. Schwartz,et al.  Disseminated intravascular coagulation in childhood acute lymphocytic leukemia with poor prognostic features , 1978, Cancer.

[21]  P. Coccia,et al.  The effect of L‐asparaginase on plasma coagulation factors in acute lymphoblastic leukemia , 1977 .

[22]  H. L. Nossel,et al.  Unique pattern of fibrinogen cleavage by human leukocyte proteases. , 1977, Blood.

[23]  K. Havemann,et al.  Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. , 1977, Blood.

[24]  J. Lindenbaum,et al.  Chronic intravascular coagulation associated with chronic myelocytic leukemia. Use of heparin in connection with a surgical procedure. , 1976, The American journal of medicine.

[25]  C. Ludlam,et al.  Platelet and fibrinogen survival in acute promyelocytic leukaemia. , 1976, British medical journal.

[26]  C. Bloomfield,et al.  Acute monoblastic leukemia: diagnosis and treatment of ten cases. , 1975, Blood.

[27]  T. Edgington,et al.  An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. , 1975, The Journal of clinical investigation.

[28]  R. Graham,et al.  The platelet defect in leukemia. Platelet ultrastructure, adenine nucleotide metabolism, and the release reaction. , 1975, The Journal of clinical investigation.

[29]  C. Sultan,et al.  The Procoagulant Factor of Leukaemic Promyelocytes: Demonstration of Immunologic Cross Reactivity with Human Brain Tissue Factor , 1975, British journal of haematology.

[30]  H. Gralnick,et al.  ACUTE PROMYELOCYTIC LEUKAEMIA: HAEMORRHAGIC MANIFESTATION AND MORPHOLOGIC CRITERIA , 1975, British journal of haematology.

[31]  S. Goodnight.  BLEEDING AND INTRAVASCULAR CLOTTING IN MALIGNANCY: A REVIEW , 1974, Annals of the New York Academy of Sciences.

[32]  M. Boiron,et al.  Acute promyelocytic leukemia: results of treatment by daunorubicin. , 1973, Blood.

[33]  B. Dreyfus,et al.  Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia , 1973, Cancer.

[34]  H. Gralnick,et al.  Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic Leukaemia , 1973, British journal of haematology.

[35]  H. Gralnick,et al.  Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. , 1972, Blood.

[36]  H. Gralnick,et al.  Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. , 1972, The American journal of medicine.

[37]  A. Polliack,et al.  Acute promyelocytic leukemia with disseminated intravascular coagulation. , 1971, American journal of clinical pathology.

[38]  F. Raafat,et al.  HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING. , 1964, Annals of internal medicine.

[39]  M. Goldberg,et al.  Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia , 1987 .

[40]  P. Bierling,et al.  Acute promyelocytic leukemia in 57 previously untreated patients , 1985, Cancer.

[41]  Cai Ms.  Adverse reactions of L-asparaginase. , 1982, The American journal of pediatric hematology/oncology.

[42]  E. Vellenga,et al.  Normal levels of antithrombin III in acute leukemia complicated by coagulopathy. , 1980, Acta haematologica.

[43]  H. Sise,et al.  Coagulation defects in acute promyelocytic leukemia. , 1969, Archives of internal medicine.